Literature DB >> 30500280

Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis.

Brigitte M Ronnett1.   

Abstract

CONTEXT.—: Distinction of hydatidiform moles from nonmolar specimens and subclassification of hydatidiform moles as complete hydatidiform mole versus partial hydatidiform mole are important for clinical practice and investigational studies. Risk of persistent gestational trophoblastic disease and clinical management differ for these entities. Diagnosis based on morphology is subject to interobserver variability and remains problematic, even for experienced gynecologic pathologists. OBJECTIVES.—: To explain how ancillary techniques target the unique genetic features of hydatidiform moles to establish diagnostic truth, highlight the issue of diagnostic reproducibility and importance of diagnostic accuracy, and illustrate use of p57 immunohistochemistry and polymerase chain reaction-based DNA genotyping for diagnosis. DATA SOURCES.—: Sources are the author's 10-year experience using ancillary techniques for the evaluation of potentially molar specimens in a large gynecologic pathology practice and the literature. CONCLUSIONS.—: The unique genetics of complete hydatidiform moles (purely androgenetic), partial hydatidiform moles (diandric triploid), and nonmolar specimens (biparental, with allelic balance) allow for certain techniques, including immunohistochemical analysis of p57 expression (a paternally imprinted, maternally expressed gene) and genotyping, to refine diagnoses of hydatidiform moles. Although p57 immunostaining alone can identify complete hydatidiform moles, which lack p57 expression because of a lack of maternal DNA, this analysis does not distinguish partial hydatidiform moles from nonmolar specimens because both express p57 because of the presence of maternal DNA. Genotyping, which compares villous and decidual DNA patterns to determine the parental source and ratios of polymorphic alleles, distinguishes purely androgenetic complete hydatidiform moles from diandric triploid partial hydatidiform moles, and both of these from biparental nonmolar specimens. An algorithmic approach to diagnosis using these techniques is advocated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30500280     DOI: 10.5858/arpa.2018-0226-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  Identification of a hydatidiform mole in twin pregnancy following assisted reproduction.

Authors:  Yan Liu; Xingzheng Zheng; Yuxiang Wang; Yan Li; Congrong Liu
Journal:  J Assist Reprod Genet       Date:  2019-12-12       Impact factor: 3.412

Review 2.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

3.  Application of next-generation sequencing to preimplantation genetic testing for recurrent hydatidiform mole patients.

Authors:  Jingyi Yang; Zhiqiang Yan; Yan Liu; Xiaohui Zhu; Rong Li; Ping Liu; Liying Yan; Jie Qiao; Xu Zhi
Journal:  J Assist Reprod Genet       Date:  2021-10-04       Impact factor: 3.412

4.  Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study.

Authors:  Jin-Sung Yuk; Jong Chul Baek; Ji Eun Park; Hyen Chul Jo; Ji Kwon Park; In Ae Cho
Journal:  PeerJ       Date:  2019-02-20       Impact factor: 2.984

5.  Expression of p57 immunomarker in the classification and differential diagnosis of partial and complete hydatidiform moles.

Authors:  Santosh Kumar Mondal; Saikat Mandal; Saptarshi Bhattacharya; Utpal Kumar Panda; Arpan Ray; Sk Moyaraf Ali
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

6.  Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles.

Authors:  Jennifer R King; Melissa L Wilson; Szabolcs Hetey; Peter Kiraly; Koji Matsuo; Antonio V Castaneda; Eszter Toth; Tibor Krenacs; Petronella Hupuczi; Paulette Mhawech-Fauceglia; Andrea Balogh; Andras Szilagyi; Janos Matko; Zoltan Papp; Lynda D Roman; Victoria K Cortessis; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

7.  p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.

Authors:  Helle Lund; Søren Nielsen; Anni Grove; Mogens Vyberg; Lone Sunde
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-10

8.  Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.

Authors:  Deyin Xing; Emily Adams; Jialing Huang; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

9.  Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.

Authors:  Deyin Xing; Karin Miller; Katie Beierl; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2022-01-01       Impact factor: 6.298

10.  Parental contribution to trisomy in heterozygous androgenetic complete moles.

Authors:  Hirokazu Usui; Asuka Sato; Makio Shozu
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.